The DOI matches its Crossref record; 101 of the 102 references it cites were found in a registry or an index.
Cancer and the chemokine network
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CXCL1 and 2 are 90% identical by amino-acid sequence and signal through the same receptor CXCR2 (Balkwill, 2004).”
From A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis (2012) · cites this paper as Balkwill, 2004
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Self-citationInternational Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,923
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1256 · Cited by 3,413
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Käkönen, S.-M., Cordon‐Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,605
Flagged first, then by citations
1 of the 102 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Darash-Yahana, M. et al. Human prostate cancer growth, vascularisation and metastasis is stimulated via high expression levels of the chemokine receptor CXCR4. Proc. Am. Assoc. Cancer Res. 44, 789 (2003).
Cited by
Sorted by citations
Items 201–300 of 1,000
Mast cells have a protumorigenic role in human thyroid cancer
Melillo, R. M., Guarino, V., Avilla, E., Galdiero, M. R., Liotti, F., Prevete, N., Rossi, F. W., Basolo, F., Ugolini, C., de Paulis, A., et al. (2010) · Oncogene · doi:10.1038/onc.2010.348 · Cited by 222
Immune Microenvironment in Tumor Progression: Characteristics and Challenges for Therapy
Chew, V., Toh, H. C., & Abastado, J. (2012) · Journal of Oncology · doi:10.1155/2012/608406 · Cited by 224
An Insight into GPCR and G-Proteins as Cancer Drivers
Chaudhary, P. K., & Kim, S. (2021) · Cells · doi:10.3390/cells10123288 · Cited by 233
The multiple faces of CXCL12 (SDF-1α) in the regulation of immunity during health and disease
Karin, N. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0909602 · Cited by 224
Tumor-Cell Homing to Lymph Nodes and Bone Marrow and CXCR4 Expression in Esophageal Cancer
Kaifi, J. T., Yekebas, E. F., Schurr, P., Obonyo, D., Wachowiak, R., Busch, P., Heinecke, A., Pantel, K., & Izbicki, J. R. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji431 · Cited by 221
Multiple Roles of Chemokine (C-C Motif) Ligand 2 in Promoting Prostate Cancer Growth
Zhang, J., Lu, Y., & Pienta, K. J. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq044 · Cited by 222
Chemokines in cancer related inflammation
Allavena, P., Germano, G., Marchesi, F., & Mantovani, A. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.11.013 · Cited by 220
G Protein-Coupled Receptors in Cancer
Bar‐Shavit, R., Maoz, M., Kancharla, A., Nag, J. K., Agranovich, D., Grisaru‐Granovsky, S., & Uziely, B. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081320 · Cited by 223
Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA
Kyte, J. A., Mu, L., Aamdal, S., Kvalheim, G., Dueland, S., Hauser, M., Gullestad, H. P., Ryder, T., Lislerud, K., Hammerstad, H., et al. (2006) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700961 · Cited by 219
Gal, A., Sjöblom, T., Fedorova, L., Imreh, S., Beug, H., & Moustakas, A. (2007) · Oncogene · doi:10.1038/sj.onc.1210741 · Cited by 212
LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer
Shen, D., Pang, J., Bi, Y., Zhao, L., Li, Y.-R., Zhao, L., Gao, Y., Wang, B., Wang, N., Wei, L., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01557-1 · Cited by 215
β 1 integrin function in vivo: Adhesion, migration and more
Brakebusch, C., & Fässler, R. (2005) · Cancer and Metastasis Reviews · doi:10.1007/s10555-005-5132-5 · Cited by 210
Vijayaraghavan, S., Lipfert, L., Chevalier, K. M., Bushey, B. S., Henley, B., Lenhart, R., Sendecki, J. A., Beqiri, M., Millar, H. J., Packman, K. E., et al. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0071 · Cited by 216
The Role of Lysyl Oxidase in SRC-Dependent Proliferation and Metastasis of Colorectal Cancer
Baker, A., Cox, T. R., Bird, D., Lang, G., Murray, G. I., Sun, X., Southall, S. M., Wilson, J. R., & Erler, J. T. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq569 · Cited by 206
Long, H., Xie, R., Xiang, T., Zhao, Z., Lin, S., Liang, Z., Chen, Z., & Zhu, B. (2012) · Stem Cells · doi:10.1002/stem.1194 · Cited by 204
Heng, B. C., Aubel, D., & Fussenegger, M. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.08.017 · Cited by 216
Sheng, G., Gao, Y., Yong, Y., & Wu, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.780264 · Cited by 215
Marchesi, F., Piemonti, L., Fedele, G., Destro, A., Roncalli, M. G., Albarello, L., Doglioni, C., Anselmo, A., Doni, A., Bianchi, P. P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1810 · Cited by 209
FOS-1 Promotes Basement-Membrane Removal during Anchor-Cell Invasion in C. elegans
Sherwood, D. R., Butler, J. A., Kramer, J. M., & Sternberg, P. W. (2005) · Cell · doi:10.1016/j.cell.2005.03.031 · Cited by 197
The Role of Immunoglobulin Superfamily Cell Adhesion Molecules in Cancer Metastasis
Wong, C.-W., Dye, D. E., & Coombe, D. R. (2012) · International Journal of Cell Biology · doi:10.1155/2012/340296 · Cited by 210
Inflammation-mediated promotion of invasion and metastasis
Solinas, G., Marchesi, F., Garlanda, C., Mantovani, A., & Allavena, P. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9227-2 · Cited by 205
Molecular mechanisms and clinical management of cancer bone metastasis
Wang, M., Xia, F., Wei, Y., & Wei, X. (2020) · Bone Research · doi:10.1038/s41413-020-00105-1 · Cited by 204
The integrative roles of chemokines at the maternal–fetal interface in early pregnancy
Du, M., Wang, S., & Li, D. (2014) · Cellular and Molecular Immunology · doi:10.1038/cmi.2014.68 · Cited by 195
PET Imaging of CXCR4 Receptors in Cancer by a New Optimized Ligand
Demmer, O., Gourni, E., Schumacher, U., Kessler, H., & Wester, H. (2011) · ChemMedChem · doi:10.1002/cmdc.201100320 · Cited by 198
Kharaishvili, G., Simkova, D., Bouchalova, K., Gachechiladze, M., Narsia, N., & Bouchal, J. (2014) · Cancer Cell International · doi:10.1186/1475-2867-14-41 · Cited by 197
Tabung, F. K., Steck, S. E., Ma, Y., Liese, A. D., Zhang, J., Caan, B., Hou, L., Johnson, K. C., Mossavar-Rahmani, Y., Shivappa, N., et al. (2015) · Cancer Causes & Control · doi:10.1007/s10552-014-0515-y · Cited by 193
Tumor microenvironment: a main actor in the metastasis process
Spano, D., & Zollo, M. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9457-5 · Cited by 199
Roles of IL-8 in Ocular Inflammations: A Review
Ghasemi, H., Ghazanfari, T., Yaraee, R., Faghihzadeh, S., & Hassan, Z. M. (2011) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2011.618902 · Cited by 195
Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12
Singh, A. K., Arya, R. K., Trivedi, A. K., Sanyal, S., Baral, R., Dormond, O., Briscoe, D. M., & Datta, D. B. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.08.007 · Cited by 194
CXCL10 Promotes Invasion-Related Properties in Human Colorectal Carcinoma Cells
Zipin‐Roitman, A., Meshel, T., Sagi‐Assif, O., Shalmon, B., Avivi, C., Pfeffer, R. M., Witz, I. P., & Ben‐Baruch, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3087 · Cited by 194
Guo, Z. S., Thorne, S. H., & Bartlett, D. L. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.02.001 · Cited by 198
Chemokines in tumor progression and metastasis
Tanaka, T. T., Bai, Z., Srinoulprasert, Y., Yang, B., Hayasaka, H., & Miyasaka, M. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00059.x · Cited by 190
Significance and Mechanism of Lymph Node Metastasis in Cancer Progression
Kawada, K., & Taketo, M. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3277 · Cited by 195
Contribution of adipose tissue to development of cancer
Cozzo, A. J., Fuller, A. M., & Makowski, L. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c170008 · Cited by 188
André, F., Cabıoğlu, N., Assi, H. I., Sabourin, J., Delaloge, S., Şahin, A., Broglio, K. R., Spano, J., Combadière, C., BUCANA, C. D., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl053 · Cited by 190
Waerner, T., Alacakaptan, M., Tamir, I. H., Oberauer, R., Gal, A., Brabletz, T., Schreiber, M., Jechlinger, M., & Beug, H. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.07.020 · Cited by 185
Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy
Bule, P., Aguiar, S. I., Aires‐da‐Silva, F., & Dias, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189804 · Cited by 196
Translating an Antagonist of Chemokine Receptor CXCR4: From Bench to Bedside
Wong, D., & Korz, W. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4846 · Cited by 186
Zhou, S., Zhou, Z., Hu, Z., Li, X., Huang, X., Wang, Z., Fan, J., Dai, Z., & Zhou, J. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.11.044 · Cited by 185
Molecular pathways and targets in cancer-related inflammation
Mantovani, A., Garlanda, C., & Allavena, P. (2010) · Annals of Medicine · doi:10.3109/07853890903405753 · Cited by 182
CXC chemokines located in the 4q21 region are up-regulated in breast cancer
Bieche, I., Chavey, C., Andrieu, C., Busson, M., Vacher, S., Le Corre, L., Guinebretiere, J.-M., Burlinchon, S., Lidereau, R., & Lazennec, G. (2007) · Endocrine Related Cancer · doi:10.1677/erc.1.01301 · Cited by 183
Biophysical models of tumour growth
Tracqui, P. (2009) · Reports on Progress in Physics · doi:10.1088/0034-4885/72/5/056701 · Cited by 191
Molecular pathways in cancer-related inflammation
Del Prete, A., Allavena, P., Santoro, G., Fumarulo, R., Corsi, M. M., & Mantovani, A. (2011) · Biochemia Medica · doi:10.11613/bm.2011.036 · Cited by 181
Anti-HIV drugs for cancer therapeutics: back to the future?
Chow, W. A., Jiang, C., & Guan, M. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70334-6 · Cited by 189
HDAC inhibition potentiates immunotherapy in triple negative breast cancer
Terranova-Barberio, M., Thomas, S., Ali, N., Pawlowska, N., Park, J., Krings, G., Rosenblum, M. D., Budillon, A., & Munster, P. N. (2017) · Oncotarget · doi:10.18632/oncotarget.23169 · Cited by 182
Wu, V. H., Yeerna, H., Nohata, N., Chiou, J., Harismendy, O., Raimondi, F., Inoue, A., Russell, R. B., Tamayo, P., & Gutkind, J. S. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.005601 · Cited by 185
Overmeire, E. V., Laoui, D., Keirsse, J., Ginderachter, J. A. V., & Sarukhan, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00127 · Cited by 186
Emerging targeted agents in metastatic breast cancer
Zardavas, D., Baselga, J. M., & Piccart, M. J. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.29 · Cited by 184
Chen, R., Alvero, A. B., Silasi, D., & Mor, G. (2007) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2006.00441.x · Cited by 182
Mozobil® (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration
Clercq, E. D. (2019) · Antiviral chemistry & chemotherapy · doi:10.1177/2040206619829382 · Cited by 179
Kitamura, T., Fujishita, T., Loetscher, P., Révész, L., Hashida, H., Kizaka‐Kondoh, S., Aoki, M., & Taketo, M. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002372107 · Cited by 180
Inflammation, proteases and cancer
van Kempen, L. C. L. T., de Visser, K. E., & Coussens, L. M. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.004 · Cited by 181
SQUARIZE, C. H., CASTILHO, R. M., Sriuranpong, V., Júnior, D. D. S. P., & Gutkind, J. S. (2006) · Neoplasia · doi:10.1593/neo.06274 · Cited by 176
Kim, J., Mori, T., Chen, S. L., Amersi, F. F., Martinez, S. R., Kuo, C. T., Turner, R. R., Ye, X., Bilchik, A. J., Morton, D. L., et al. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000217690.65909.9c · Cited by 185
GPCRs: Emerging anti-cancer drug targets
Nieto, A., & McDonald, P. H. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.09.005 · Cited by 173
Shanmugam, M. K., Ahn, K. S., Hsu, A., Woo, C. C., Yuan, Y., Tan, K. H. B., Chinnathambi, A., Alahmadi, T. A., Alharbi, S. A., Koh, A. P.-F., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01294 · Cited by 176
Eiró, N. (2012) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v4.i3.62 · Cited by 181
Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy
Sleightholm, R. L., Neilsen, B. K., Li, J., Steele, M. M., Singh, R. K., Hollingsworth, M. A., & Oupický, D. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.05.012 · Cited by 171
Therapeutic antibodies directed at G protein-coupled receptors
Hutchings, C. J., Koglin, M., & Marshall, F. H. (2010) · mAbs · doi:10.4161/mabs.2.6.13420 · Cited by 176
Maussang, D., Langemeijer, E., Fitzsimons, C. P., van Walsum, M., Dijkman, R., Borg, M. K., Slinger, E., Schreiber, A., Michel, D., Tensen, C. P., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2487 · Cited by 172
Nanomedicine‐Based Immunotherapy for the Treatment of Cancer Metastasis
Zhang, P., Zhai, Y., Cai, Y., Zhao, Y., & Li, Y. (2019) · Advanced Materials · doi:10.1002/adma.201904156 · Cited by 170
Sun, Y.-X., Fang, M., Wang, J., Cooper, C. R., Pienta, K. J., & Taichman, R. S. (2006) · The Prostate · doi:10.1002/pros.20500 · Cited by 177
Evolving immunosuppressive microenvironment during human cervical carcinogenesis
Kobayashi, A., WEINBERG, V. K., Darragh, T. M., & Smith‐McCune, K. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.33 · Cited by 170
Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients
Granger, J. M., & Kontoyiannis, D. P. (2009) · Cancer · doi:10.1002/cncr.24480 · Cited by 170
Modulation of the tumor vasculature and oxygenation to improve therapy
Siemann, D. W., & Horsman, M. R. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.06.006 · Cited by 169
Paving the Rho in cancer metastasis: Rho GTPases and beyond
Jansen, S. R., Gosens, R., Wieland, T., & Schmidt, M. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.09.002 · Cited by 171
Chemokines in tumor angiogenesis and metastasis
Singh, S., Sadanandam, A., & Singh, R. K. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9068-9 · Cited by 170
Laubli, H. P., Spanaus, K. S., & Borsig, L. (2009) · Blood · doi:10.1182/blood-2008-10-186585 · Cited by 166
Saintigny, P., Massarelli, E., Lin, S. H., Ahn, Y., Chen, Y., Goswami, S., Erez, B., O’Reilly, M. S., Liu, D., Lee, J. J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0263 · Cited by 165
Ye, J., Wu, X., Wu, D., Wu, P., Ni, C., Zhang, Z., Chen, Z., Qiu, F., Xu, J., & Huang, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060687 · Cited by 167
Histological and immunological features of non‐eosinophilic nasal polyps
Kim, J., Hong, S., Kim, Y., Lee, C. H., Min, Y., & Rhee, C. (2007) · Otolaryngology · doi:10.1016/j.otohns.2007.07.036 · Cited by 166
Wu, Y., Li, Y.-Y., Matsushima, K., Baba, T., & Mukaida, N. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6384 · Cited by 171
Decaestecker, C., Debeir, O., Ham, P. V., & Robert Kiss, A. (2006) · Medicinal Research Reviews · doi:10.1002/med.20078 · Cited by 169
Narducci, M. G., Scala, E., Bresin, A., Caprini, E., Picchio, M. C., Remotti, D., Ragone, G., Nasorri, F., Frontani, M., Arcelli, D., et al. (2005) · Blood · doi:10.1182/blood-2005-04-1492 · Cited by 165
Shurin, M. R., Shurin, G. V., Lokshin, A. E., Yurkovetsky, Z. R., Gutkin, D. W., Chatta, G. S., Zhong, H., Han, B., & Ferris, R. L. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9010-6 · Cited by 166
Barderas, R., Bartolomé, R. A., Fernández‐Aceñero, M. J., Torres, S., & Casal, J. I. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4090 · Cited by 166
Epithelial-mesenchymal transition and inflammation at the site of the primary tumor
Dominguez, C. L., David, J. M., & Palena, C. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.08.002 · Cited by 163
Next-generation computational tools for interrogating cancer immunity
Finotello, F., Rieder, D., Hackl, H., & Trajanoski, Z. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0166-7 · Cited by 161
NF-κB as a central regulator of macrophage function in tumors
Biswas, S. K., & Lewis, C. E. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0310153 · Cited by 166
Szkandera, J., Gerger, A., Liegl‐Atzwanger, B., Absenger, G., Stotz, M., Friesenbichler, J., Trajanoski, S., Stojaković, T., Eberhard, K., Leithner, A., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28677 · Cited by 160
Peptide-based nanoprobes for molecular imaging and disease diagnostics
Zhang, P., Cui, Y., Anderson, C. F., Zhang, C., Li, Y., Wang, R., & Cui, H. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00793k · Cited by 160
He, H., Guo, C., Wang, J., Korzun, W. J., Wang, X., Ghosh, S., & Yang, H. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b01892 · Cited by 161
Sweeney, C. J., Mehrotra, S., Sadaria, M. R., Kumar, S., Shortle, N. H., Roman, Y., Sheridan, C., Campbell, R. A., Murry, D. J., Badve, S., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0030 · Cited by 156
Chheda, Z. S., Sharma, R. K., Jala, V. R., Luster, A. D., & Haribabu, B. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502376 · Cited by 159
Matsumura, S., & Demaria, S. (2010) · Radiation Research · doi:10.1667/rr1860.1 · Cited by 159
Wu, H., Hwang‐Verslues, W. W., Lee, W.-H., Huang, C.-K., Wei, P., Chen, C.-L., Shew, J., Lee, E. Y.-H. P., Jeng, Y., Tien, Y., et al. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20141702 · Cited by 160
Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis
Adekoya, T. O., & Richardson, R. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124449 · Cited by 160
Zhang, H., Yue, J., Jiang, Z., Zhou, R., Xie, R., Xu, Y., & Wu, S. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.180 · Cited by 156
Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism
Cambien, B., Karimdjee-Soilihi, B., Richard, P., Bziouech, H., Barthel, R., Millet, M. A., Martini, V., Birnbaum, D., Scoazec, J., Abello, J., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605078 · Cited by 148
Chemotherapy-induced metastasis: mechanisms and translational opportunities
Karagiannis, G. S., Condeelis, J. S., & Oktay, M. H. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-017-9870-x · Cited by 158
Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization
Marcuzzi, E., Angioni, R., Molon, B., & Calì, B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010096 · Cited by 162
Kulbe, H., Hagemann, T., Szlosarek, P. W., Balkwill, F. R., & Wilson, J. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0957 · Cited by 158
Self-citationKumagai, S., Itahashi, K., & Nishikawa, H. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00870-6 · Cited by 171
The molecular basis of hypertrophic scars
Zhu, Z., Ding, J., & Tredget, E. E. (2016) · Burns & Trauma · doi:10.1186/s41038-015-0026-4 · Cited by 156
Chemokine Function in Periodontal Disease and Oral Cavity Cancer
Sahingur, S. E., & Yeudall, W. A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00214 · Cited by 157
LONG, X., Ye, Y., Zhang, L., Liu, P., Yu, W., Wei, F., Ren, X., & Yu, J. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3234 · Cited by 160
Vetrano, S., Borroni, E. M., Sarukhan, A., Savino, B., Bonecchi, R., Correale, C., Arena, V., Fantini, M. C., Roncalli, M. G., Malesci, A., et al. (2009) · Gut · doi:10.1136/gut.2009.183772 · Cited by 155
Ji, J., Eggert, T., Budhu, A., Forgues, M., Takai, A., Dang, H. T., Ye, Q., Lee, J., Kim, J. H., Greten, T. F., et al. (2015) · Hepatology · doi:10.1002/hep.27822 · Cited by 155
Zumwalt, T. J., Arnold, M., Goel, A., & Boland, C. R. (2014) · Oncotarget · doi:10.18632/oncotarget.3205 · Cited by 152
Building the niche: The role of the S100 proteins in metastatic growth
Lukanidin, E. M., & Sleeman, J. P. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.02.006 · Cited by 152
Metadata
- Authors
- Balkwill, F.
- Venue
- Nature Reviews Cancer
- Published
- 2004-07
- Volume
- 4
- Issue
- 7
- Pages
- 540-550
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1986986419
- Cited by
- 2,343
- References
- 102
- Citations by year
- 2026: 31 · 2025: 45 · 2024: 57 · 2023: 82 · 2022: 112 · 2021: 132 · 2020: 122 · 2019: 84 · 2018: 131 · 2017: 127 · 2016: 134 · 2015: 133 · 2014: 152 · 2013: 119 · 2012: 135
- FWCI
- 9.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- chemokines, chemokine receptors, carcinogenesis, metastasis, tumor-host interaction, metastatic potential, site-specific metastasis, chemokine receptor antagonists, inflammation, autoimmune disease, cancer therapy
- MeSH terms
- Animals, Antineoplastic Agents, Autoimmune Diseases, Chemotaxis, Leukocyte, Humans, Inflammation, Macrophage Activation, Mice, Nude, Models, Biological, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasm Proteins, Neoplasms, Lymphocytes, Tumor-Infiltrating, Chemokines, Receptors, Chemokine, Xenograft Model Antitumor Assays, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review